0554437 - BFÚ 2022 RIV GB eng J - Journal Article
Radaszkiewicz, T. - Noskova, M. - Gomoryova, K. - Blanářová, O. - Radaszkiewicz, K. A. - Pícková, Markéta - Víchová, Ráchel - Gybel, T. - Kaiser, K. - Demkova, L. - Kučerová, L. - Bárta, T. - Potessil, D. - Zdráhal, Z. - Souček, Karel - Bryja, Vítězslav
RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.
eLife. Roč. 10, OCT 27 2021 (2021), č. článku e65759. ISSN 2050-084X. E-ISSN 2050-084X
Institutional support: RVO:68081707
Keywords : planar cell polarity * beta-catenin * wnt/beta-catenin * gastric-cancer * e3 ligase * vangl2 phosphorylation
OECD category: Pharmacology and pharmacy
Impact factor: 8.713, year: 2021
Method of publishing: Open access
https://elifesciences.org/articles/65759
Permanent Link: http://hdl.handle.net/11104/0329146
Radaszkiewicz, T. - Noskova, M. - Gomoryova, K. - Blanářová, O. - Radaszkiewicz, K. A. - Pícková, Markéta - Víchová, Ráchel - Gybel, T. - Kaiser, K. - Demkova, L. - Kučerová, L. - Bárta, T. - Potessil, D. - Zdráhal, Z. - Souček, Karel - Bryja, Vítězslav
RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.
eLife. Roč. 10, OCT 27 2021 (2021), č. článku e65759. ISSN 2050-084X. E-ISSN 2050-084X
Institutional support: RVO:68081707
Keywords : planar cell polarity * beta-catenin * wnt/beta-catenin * gastric-cancer * e3 ligase * vangl2 phosphorylation
OECD category: Pharmacology and pharmacy
Impact factor: 8.713, year: 2021
Method of publishing: Open access
https://elifesciences.org/articles/65759
Permanent Link: http://hdl.handle.net/11104/0329146